Testing contrast mammography for breast MRI findings
Part of Cancer, Skin clinical trials.
This study tests whether a special type of mammogram (contrast-enhanced mammography, or CEM) can help doctors see additional breast findings that show up on MRI. It may help avoid unnecessary extra biopsies or surgeries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 75 years old.
- You have been told you have a suspicious breast finding (BI-RADS 4 or higher) and an additional finding on a breast MRI.
- You had that breast MRI within the last 14 days.
- You are not allergic to iodine contrast dye, not pregnant or breastfeeding.
- You are not receiving chemotherapy, hormone therapy, or radiation for this breast disease.
- You have not had any breast surgery (including biopsies) for this condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a special mammogram with dye (CEDM) to MRI for women already diagnosed with invasive breast cancer. The goal is to see if CEDM works as well as MRI for planning surgery, potentially offering a faster or easier option.
This study looks at whether contrast-enhanced mammography (CEM) can find breast cancer better in women who have dense breast tissue and a personal history of breast cancer. If you've had breast cancer before and have dense breasts, this trial could help improve early detection.
This study tests whether getting a contrast-enhanced mammogram (CEM) every two years is effective for detecting breast cancer in women who have had breast cancer before. If you qualify, you will receive CEM instead of a standard mammogram to see if it helps find cancer earlier.
This study tests how well a special mammogram with contrast can help assess breast cancer risk in women with dense breast tissue. It may help improve screening planning, especially when standard mammograms are harder to read due to density.
This study compares two ways of imaging the breast—molecular breast imaging (a scan that uses a small radioactive tracer) and standard breast MRI—to better find or rule out breast cancer. You may join if you are considered high risk and already have a breast MRI planned, and you can do both tests close together.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.